0000950123-23-005336.txt : 20230515 0000950123-23-005336.hdr.sgml : 20230515 20230515161545 ACCESSION NUMBER: 0000950123-23-005336 CONFORMED SUBMISSION TYPE: 13F-NT PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230515 DATE AS OF CHANGE: 20230515 EFFECTIVENESS DATE: 20230515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bain Capital Life Sciences Fund III, L.P. CENTRAL INDEX KEY: 0001875273 IRS NUMBER: 871342200 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-NT SEC ACT: 1934 Act SEC FILE NUMBER: 028-22979 FILM NUMBER: 23922560 BUSINESS ADDRESS: STREET 1: 200 CLARENDON ST CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 16175162000 MAIL ADDRESS: STREET 1: 200 CLARENDON ST CITY: BOSTON STATE: MA ZIP: 02116 13F-NT 1 primary_doc.xml X0202 13F-NT LIVE 0001875273 XXXXXXXX 03-31-2023 03-31-2023 false Bain Capital Life Sciences Fund III, L.P.

200 Clarendon St Boston MA 02116

13F NOTICE 028-22979 28-18477 Bain Capital Life Sciences Investors, LLC 28-22975 Bain Capital Life Sciences III General Partner, LLC Y The report on Form 13F for the period ended March 31, 2023 for Bain Capital Life Sciences Fund III, L.P. (the "Fund") is being filed by Bain Capital Life Sciences Investors, LLC, which is the manager of Bain Capital Life Sciences III General Partner, LLC, which is the general partner of the Fund. Adam Koppel 617-516-2000 /s/ Adam Koppel Boston MA 05-15-2023